51 related articles for article (PubMed ID: 38474205)
21. KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer.
Jaromi L; Csongei V; Vesel M; Abdelwahab EMM; Soltani A; Torok Z; Smuk G; Sarosi V; Pongracz JE
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065402
[TBL] [Abstract][Full Text] [Related]
22. Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.
Wang X; Ricciuti B; Nguyen T; Li X; Rabin MS; Awad MM; Lin X; Johnson BE; Christiani DC
Cancer Res; 2021 May; 81(9):2566-2573. PubMed ID: 33653773
[TBL] [Abstract][Full Text] [Related]
23. Influence of EGFR-activating mutations on sensitivity to tyrosine kinase inhibitors in a KRAS mutant non-small cell lung cancer cell line.
Tsukumo Y; Naito M; Suzuki T
PLoS One; 2020; 15(3):e0229712. PubMed ID: 32130260
[TBL] [Abstract][Full Text] [Related]
24. Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study.
Aramini B; Banchelli F; Bettelli S; Manfredini S; D'Amico R; Masciale V; Pinelli M; Moretti M; Stefani A; Bertolini F; Dominici M; Morandi U; Maiorana A
Oncotarget; 2020 Feb; 11(5):550-559. PubMed ID: 32082488
[No Abstract] [Full Text] [Related]
25. Genomic and immune profiling of pre-invasive lung adenocarcinoma.
Chen H; Carrot-Zhang J; Zhao Y; Hu H; Freeman SS; Yu S; Ha G; Taylor AM; Berger AC; Westlake L; Zheng Y; Zhang J; Ramachandran A; Zheng Q; Pan Y; Zheng D; Zheng S; Cheng C; Kuang M; Zhou X; Zhang Y; Li H; Ye T; Ma Y; Gao Z; Tao X; Han H; Shang J; Yu Y; Bao D; Huang Y; Li X; Zhang Y; Xiang J; Sun Y; Li Y; Cherniack AD; Campbell JD; Shi L; Meyerson M
Nat Commun; 2019 Nov; 10(1):5472. PubMed ID: 31784532
[TBL] [Abstract][Full Text] [Related]
26. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer.
Harrison PT; Vyse S; Huang PH
Semin Cancer Biol; 2020 Apr; 61():167-179. PubMed ID: 31562956
[TBL] [Abstract][Full Text] [Related]
27. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.
Skoulidis F; Heymach JV
Nat Rev Cancer; 2019 Sep; 19(9):495-509. PubMed ID: 31406302
[TBL] [Abstract][Full Text] [Related]
28. Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2).
Beau-Faller M; Texier M; Blons H; Richard N; Escande F; Melaabi S; Lizard S; De Fraipont F; Longchampt E; Morin F; Zalcman G; Pignon JP; Cadranel J
Clin Lung Cancer; 2019 May; 20(3):222-230. PubMed ID: 30679079
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.
Inamura K
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690599
[TBL] [Abstract][Full Text] [Related]
30. Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance.
Yu HA; Suzawa K; Jordan E; Zehir A; Ni A; Kim R; Kris MG; Hellmann MD; Li BT; Somwar R; Solit DB; Berger MF; Arcila M; Riely GJ; Ladanyi M
Clin Cancer Res; 2018 Jul; 24(13):3108-3118. PubMed ID: 29530932
[No Abstract] [Full Text] [Related]
31. Small-cell lung cancer: what we know, what we need to know and the path forward.
Gazdar AF; Bunn PA; Minna JD
Nat Rev Cancer; 2017 Nov; 17(12):765. PubMed ID: 29123245
[TBL] [Abstract][Full Text] [Related]
32. Effects of Co-occurring Genomic Alterations on Outcomes in Patients with
Arbour KC; Jordan E; Kim HR; Dienstag J; Yu HA; Sanchez-Vega F; Lito P; Berger M; Solit DB; Hellmann M; Kris MG; Rudin CM; Ni A; Arcila M; Ladanyi M; Riely GJ
Clin Cancer Res; 2018 Jan; 24(2):334-340. PubMed ID: 29089357
[No Abstract] [Full Text] [Related]
33. Order Matters: The Order of Somatic Mutations Influences Cancer Evolution.
Kent DG; Green AR
Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 28096247
[TBL] [Abstract][Full Text] [Related]
34. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Zhang YL; Yuan JQ; Wang KF; Fu XH; Han XR; Threapleton D; Yang ZY; Mao C; Tang JL
Oncotarget; 2016 Nov; 7(48):78985-78993. PubMed ID: 27738317
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor mutations in adenocarcinoma in situ and minimally invasive adenocarcinoma detected using mutation-specific monoclonal antibodies.
Nakamura H; Koizumi H; Kimura H; Marushima H; Saji H; Takagi M
Lung Cancer; 2016 Sep; 99():143-7. PubMed ID: 27565930
[TBL] [Abstract][Full Text] [Related]
36. Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications.
Ricciuti B; Leonardi GC; Metro G; Grignani F; Paglialunga L; Bellezza G; Baglivo S; Mencaroni C; Baldi A; Zicari D; Crinò L
Expert Rev Respir Med; 2016; 10(1):53-68. PubMed ID: 26714748
[TBL] [Abstract][Full Text] [Related]
37. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.
Qu Y; Che N; Zhao D; Zhang C; Su D; Zhou L; Zhang L; Wang C; Zhang H; Wei L
Tumour Biol; 2015 Aug; 36(8):6417-24. PubMed ID: 25813151
[TBL] [Abstract][Full Text] [Related]
38. PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.
Wang L; Hu H; Pan Y; Wang R; Li Y; Shen L; Yu Y; Li H; Cai D; Sun Y; Chen H
PLoS One; 2014; 9(2):e88291. PubMed ID: 24533074
[TBL] [Abstract][Full Text] [Related]
39. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
40. Cell of origin of lung cancer.
Sutherland KD; Berns A
Mol Oncol; 2010 Oct; 4(5):397-403. PubMed ID: 20594926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
